Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5397
-0.0556 %
$ 23 M
Market Cap
-3.17
P/E
ADAP - TOTAL RECEIVABLES
Total Receivables ADAP - Adaptimmune Therapeutics plc
46.9 M
LAST VALUE
689.89%
2 YEAR CAGR
200.34%
5 YEAR CAGR
110.58%
10 YEAR CAGR